Heron Therapeutics (HRTX) Inventory (2016 - 2026)
Heron Therapeutics' (HRTX) quarterly Inventory came in at $92.5 million in Q1 2026, up 62.54% YoY from $56.9 million in Q1 2025, and little changed on a QoQ basis from $92.7 million in Q4 2025.
Heron Therapeutics (HRTX) Inventory (2016 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 11 years of Inventory data on file, last reported at $92.5 million in Q1 2026.
- Quarterly Inventory rose 62.54% year-over-year to $92.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.5 million (up 62.54% YoY) and the FY2025 annual result came in at $92.7 million, up 74.47% from the prior year.
- Inventory steadied at $92.5 million in Q1 2026, from $92.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $92.7 million in Q4 2025 to a low of $100000.0 in Q1 2024.
- A 5-year average of $54.9 million and a median of $53.2 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2024 — Inventory plunged 99.81% — and 2025, when it surged 56832.0%.
- Tracing HRTX's Inventory over 5 years: stood at $54.6 million in 2022, then slipped by 22.84% to $42.1 million in 2023, then rose by 26.24% to $53.2 million in 2024, then surged by 74.47% to $92.7 million in 2025, then fell by 0.22% to $92.5 million in 2026.
- The last three Inventory figures came in at $92.5 million (Q1 2026), $92.7 million (Q4 2025), and $70.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Heron Therapeutics | 58.32 Mn | 15.65 Mn | 26.09 Mn | 90.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.59 Mn |
| Mar 31, 2026 | 92.54 Mn |
| Dec 31, 2025 | 92.75 Mn |
| Sep 30, 2025 | 70.03 Mn |
| Jun 30, 2025 | 72.97 Mn |
| Mar 31, 2025 | 56.93 Mn |
| Dec 31, 2024 | 53.16 Mn |
| Sep 30, 2024 | 45.95 Mn |
| Jun 30, 2024 | 42.86 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 42.11 Mn |
| Sep 30, 2023 | 42.01 Mn |
| Jun 30, 2023 | 44.62 Mn |
| Mar 31, 2023 | 52.06 Mn |
| Dec 31, 2022 | 54.57 Mn |
| Sep 30, 2022 | 52.24 Mn |
| Jun 30, 2022 | 61.32 Mn |
| Mar 31, 2022 | 56.47 Mn |
| Dec 31, 2021 | 48.38 Mn |
| Sep 30, 2021 | 41.50 Mn |